国际眼科杂志
國際眼科雜誌
국제안과잡지
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY
2014年
10期
1841-1843
,共3页
艾尼瓦尔·卡地尔%熊丽君
艾尼瓦爾·卡地爾%熊麗君
애니와이·잡지이%웅려군
复方血栓通%激光治疗%中心性浆液性脉络膜视网膜病变%性激素
複方血栓通%激光治療%中心性漿液性脈絡膜視網膜病變%性激素
복방혈전통%격광치료%중심성장액성맥락막시망막병변%성격소
compound Xueshuantong%laser treatment%central serous chorioretinopathy%hormone
目的：探讨复方血栓通联合激光治疗中心性浆液性脉络膜视网膜病变( central serous chorioretinopathy,CSCR)的临床疗效。<br> 方法：将我院治疗的181例中心性浆液性脉络膜视网膜病变患者随机分为治疗组91例和对照组90例,对照组行激光治疗,治疗组在激光治疗后口服复方血栓通；比较两组患者临床疗效、平均光敏感度和血清睾酮、雌激素水平。结果：治疗后3wk,治疗组总有效率为90.1%,对照组为72.2%,治疗组显著高于对照组(χ2=10.473,P=0.001)；治疗后6wk,治疗组总有效率亦显著高于对照组(χ2=4.499,P=0.034)。治疗组治愈时间、视力恢复时间均显著少于对照组,平均光敏感度显著高于对照组,两组间相比差异具有统计学意义(P<0.05)。治疗后两组患者相关激素水平均显著降低,其中治疗组血清激素水平降低程度显著优于对照组,组间相比差异具有统计学意义(P<0.05)。<br> 结论：复方血栓通联合激光治疗中心性浆液性脉络膜视网膜病变,能够显著提高疗效,缩短病程,有利于视功能恢复,值得临床推广。
目的：探討複方血栓通聯閤激光治療中心性漿液性脈絡膜視網膜病變( central serous chorioretinopathy,CSCR)的臨床療效。<br> 方法：將我院治療的181例中心性漿液性脈絡膜視網膜病變患者隨機分為治療組91例和對照組90例,對照組行激光治療,治療組在激光治療後口服複方血栓通；比較兩組患者臨床療效、平均光敏感度和血清睪酮、雌激素水平。結果：治療後3wk,治療組總有效率為90.1%,對照組為72.2%,治療組顯著高于對照組(χ2=10.473,P=0.001)；治療後6wk,治療組總有效率亦顯著高于對照組(χ2=4.499,P=0.034)。治療組治愈時間、視力恢複時間均顯著少于對照組,平均光敏感度顯著高于對照組,兩組間相比差異具有統計學意義(P<0.05)。治療後兩組患者相關激素水平均顯著降低,其中治療組血清激素水平降低程度顯著優于對照組,組間相比差異具有統計學意義(P<0.05)。<br> 結論：複方血栓通聯閤激光治療中心性漿液性脈絡膜視網膜病變,能夠顯著提高療效,縮短病程,有利于視功能恢複,值得臨床推廣。
목적：탐토복방혈전통연합격광치료중심성장액성맥락막시망막병변( central serous chorioretinopathy,CSCR)적림상료효。<br> 방법：장아원치료적181례중심성장액성맥락막시망막병변환자수궤분위치료조91례화대조조90례,대조조행격광치료,치료조재격광치료후구복복방혈전통；비교량조환자림상료효、평균광민감도화혈청고동、자격소수평。결과：치료후3wk,치료조총유효솔위90.1%,대조조위72.2%,치료조현저고우대조조(χ2=10.473,P=0.001)；치료후6wk,치료조총유효솔역현저고우대조조(χ2=4.499,P=0.034)。치료조치유시간、시력회복시간균현저소우대조조,평균광민감도현저고우대조조,량조간상비차이구유통계학의의(P<0.05)。치료후량조환자상관격소수평균현저강저,기중치료조혈청격소수평강저정도현저우우대조조,조간상비차이구유통계학의의(P<0.05)。<br> 결론：복방혈전통연합격광치료중심성장액성맥락막시망막병변,능구현저제고료효,축단병정,유리우시공능회복,치득림상추엄。
AIM: To explore the clinical therapeutic effect of compound Xueshuantong combined with laser treatment in central serous chorioretinopathy ( CSCR) patients. <br> METHODS: A total of 181 cases of central serous chorioretinopathy patients treated in our hospital were randomly divided into treatment group ( 91 cases ) and control group ( 90 cases ) . The patients in control group underwent laser treatment, those in treatment group received oral compound Xueshuantong after laser treatment. Clinical curative effect, the average light sensitivity and serum testosterone, estrogen levels of two group were compared. <br> RESULTS: After 3wk of treatment, the total effective rate of the treatment group was 90. 1%, 72. 2% in the control group, the treatment group was significantly higher (χ2 = 10. 473, P= 0. 001 ); After 6wk of treatment group, the total effective rate was also significantly higher than that in the control group (χ2 = 4. 499, P= 0. 034). Healing time, visual recovery time in treatment group was significantly less than those in the control group, the mean sensitivity was significantly higher, the difference between the two groups was statistical significance ( P<0.05). After the treatment the hormone of patients in the two groups were significantly decreased, the treatment to reduce the level of serum hormone level was significantly better than those in the control group, the difference between the two groups was statistical significance ( P<0.05). <br> CONCLUSION: Compound Xueshuantong combined with laser in the treatment of central serous chorioretinopathy, can significantly improve the efficacy, shorten the course of disease, is conducive to the recovery of visual function, and worth the clinical promotion.
